Display options
Cite
Gnanaraj P, Karthikeyan S, Narasimhan M, et al. Decrease in "Hamilton Rating Scale for Depression" Following Isotretinoin Therapy in Acne: An Open-Label Prospective Study. Indian J Dermatol. 2015;60(5):461-4doi: 10.4103/0019-5154.164358.
Gnanaraj, P., Karthikeyan, S., Narasimhan, M., & Rajagopalan, V. (2015). Decrease in "Hamilton Rating Scale for Depression" Following Isotretinoin Therapy in Acne: An Open-Label Prospective Study. Indian journal of dermatology, 60(5), 461-4. https://doi.org/10.4103/0019-5154.164358
Gnanaraj, Pushpa, et al. "Decrease in "Hamilton Rating Scale for Depression" Following Isotretinoin Therapy in Acne: An Open-Label Prospective Study." Indian journal of dermatology vol. 60,5 (2015): 461-4. doi: https://doi.org/10.4103/0019-5154.164358
Gnanaraj P, Karthikeyan S, Narasimhan M, Rajagopalan V. Decrease in "Hamilton Rating Scale for Depression" Following Isotretinoin Therapy in Acne: An Open-Label Prospective Study. Indian J Dermatol. 2015 Sep-Oct;60(5):461-4. doi: 10.4103/0019-5154.164358. PMID: 26538692; PMCID: PMC4601412.
Copy Download .nbib Format: NLM
Share it on

Indian J Dermatol. 2015 Sep-Oct;60(5):461-4. doi: 10.4103/0019-5154.164358.

Decrease in "Hamilton Rating Scale for Depression" Following Isotretinoin Therapy in Acne: An Open-Label Prospective Study.

Indian journal of dermatology

Pushpa Gnanaraj, Subashini Karthikeyan, Murali Narasimhan, Vaidyanathan Rajagopalan

Affiliations

  1. Department of Dermatology, SRM Medical College Hospital and Research Centre, Kattankulathur, Kancheepuram, Tamil Nadu, India.

PMID: 26538692 PMCID: PMC4601412 DOI: 10.4103/0019-5154.164358

Abstract

BACKGROUND: Acne is a common disorder among adolescents and young adults causing a considerable psychological impact including anxiety and depression. Isotretinoin, a synthetic oral retinoid is very effective in the treatment of moderate to severe acne. But there have been many reports linking isotretinoin to depression and suicide though no clear proof of association has been established so far.

OBJECTIVE: To determine whether oral isotretinoin increases the risk of depression in patients with moderate to severe acne.

MATERIALS AND METHODS: One hundred and fifty patients with moderate to severe acne were treated with oral isotretinoin 0.5 mg/kg/day for a period of 3 months. Their acne and depression scoring was done at baseline and then every month for the first 3 months and then at 6 months.

RESULTS: We found that the acne scoring reduced from 3.11 ± 0.49 to 0.65 ± 0.62 (P = < 0.001) at the end of 3 months. Also, the depression scoring decreased significantly from 3.89 ± 4.9 at the beginning of study to 0.45 ± 1.12 (P < 0.001) at the end of 3 months. Both the acne and depression scores continued to remain low at the end of 6 months at 0.5 ± 0.52 (P = < 0.001) and 0.18 ± 0.51 (P = < 0.001), respectively.

CONCLUSIONS: Our study proves that oral isotretinoin causes significant clearance of acne lesions. It causes significant reduction in depression scores and is not associated with an increased incidence of depression or suicidal tendencies.

Keywords: Acne; depression; isotretinoin

References

  1. J Am Acad Dermatol. 2003 Aug;49(2):171-82; quiz 183-6 - PubMed
  2. Cutis. 1984 May;33(5):484-6, 489 - PubMed
  3. Br J Gen Pract. 2005 Feb;55(511):134-8 - PubMed
  4. J Am Acad Dermatol. 2003 Sep;49(3):424-32 - PubMed
  5. Pediatr Dermatol. 1996 Jul-Aug;13(4):350 - PubMed
  6. Br J Dermatol. 1997 Jan;136(1):66-70 - PubMed
  7. J Reprod Med. 2008 Sep;53(9 Suppl):742-52 - PubMed
  8. Arch Dermatol. 2005 May;141(5):557-60 - PubMed
  9. J Cutan Med Surg. 2000 Apr;4(2):66-70 - PubMed
  10. Dermatoendocrinol. 2009 May;1(3):162-9 - PubMed
  11. Br Med J. 1980 Jun 14;280(6229):1394-6 - PubMed
  12. J Cosmet Dermatol. 2010 Mar;9(1):59-63 - PubMed
  13. Eur J Neurosci. 2008 May;27(9):2363-72 - PubMed
  14. N Engl J Med. 2001 Feb 8;344(6):460 - PubMed
  15. Arch Dermatol. 2002 Dec;138(12):1584-90 - PubMed
  16. J Am Acad Dermatol. 2001 Oct;45(4):515-9 - PubMed
  17. Arch Dermatol. 2000 Oct;136(10 ):1231-6 - PubMed
  18. BMJ. 2006 Nov 4;333(7575):949-53 - PubMed
  19. Indian J Dermatol Venereol Leprol. 2009 May-Jun;75(3):323-6 - PubMed

Publication Types